Unusual specific interaction of RBD with zeolite induces rapid neutralization of SARS-CoV-2

Author:

Fan Jie1ORCID,Li Dan1,Liu Shenxin1,Zhu Miaojin1,Zhang Tongtong2,Yu Lisha1,He Min3,Chen Xutao1,Wang Fangjun4ORCID,Zhang Hang5,Liu Zhuang5ORCID,Shi Yifeng6,Chen Hao1,Zhang Wenzhao1,Shi Chaojie1,Weng Tianhao1,Shi Danrong7,Zou Shihui1ORCID,Wang Qi8ORCID,Chen Wei9ORCID,Wu Nanping10,YAO Hang-Ping11ORCID,Xiao Liping1

Affiliation:

1. Zhejiang University

2. Department of Cell Biology and Department of Cardiology of the Second Affiliated Hospital, Zhejiang University School of Medicine

3. Dalian Institute of Chemical Physics

4. Chinese Academy of Science

5. Soochow University

6. Zeo-Innov Life Technology Co., Ltd.

7. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, Zhejiang University School of Medicine,

8. Zhejiang Uniersity

9. Department of Cell Biology and Department of Cardiology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

10. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases

11. First Affiliated Hospital Zhejiang University

Abstract

Abstract RBD-ACE2 interaction is critical in mediating SARS-CoV-2 attachment to its host cells. Blocking the attachment by inhibiting RBD-ACE2 binding is an effective way to prevent COVID-19 infection. In this study, we demonstrate that copper-ion exchanged zeolite (Cu-zeolite) binds specifically to RBD of SARS-CoV-2 via an unusual specific copper-content-dependent interaction of Cu-zeolite with RBD. Accordingly, Cu-zeolites prevent the virions from interacting with host cells, contributing to efficient and rapid SARS-CoV-2 neutralization. Therefore, Cu-zeolite has the potential to serve as a feasible and effective preventive measure to reduce exposure to the virus and as a therapeutic agent for post-exposure treatment of COVID-19.

Publisher

Research Square Platform LLC

Reference50 articles.

1. A novel coronavirus from patients with pneumonia in China, 2019;Zhu N;N Engl J Med,2020

2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang C;Lancet,2020

3. Coronavirus Disease 2019 (COVID-19) pandemic. Numbers at a glance. (Accessed at 3rd of May), https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (

4. COVID-19: A call for physical scientists and engineers;Huang H;ACS Nano,2020

5. COVID-19: Transmission, prevention, and potential therapeutic opportunities;Lotfi M;Clin Chim Acta,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3